Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-17-002876
Filing Date
2017-10-25
Accepted
2017-10-25 08:12:06
Documents
1
Period of Report
2017-10-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1720650.html 4  
1 OWNERSHIP DOCUMENT zk1720650.xml 4 5412
  Complete submission text file 0001178913-17-002876.txt   7062
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Issuer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2890 Miscellaneous Chemical Products

Mailing Address 6725 MESA RIDGE ROAD SUITE 100 SAN DIEGO CA 92121
Business Address
Culley Brian M (Reporting) CIK: 0001310683 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24431 | Film No.: 171152106